Psychosocial, attitudinal, and demographic correlates of cancer-related germline genetic testing in the 2017 Health Information National Trends Survey

Roberts, MC; Turbitt, E; Klein, WMP

Psychosocial, attitudinal, and demographic correlates of cancer-related germline genetic testing in the 2017 Health Information National Trends Survey

Roberts, MC Turbitt, E

Klein, WMP

Permalink

Publication Type:: Journal Article
Citation:: Journal of Community Genetics, 2019, 10 (4), pp. 453 - 459
Issue Date:: 2019-10-01

Closed Access

	Filename	Description	Size
	Roberts2019_Article_PsychosocialAttitudinalAndDemo.pdf	Published Version	278.94 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Roberts, MC	en_US
dc.contributor.author	Turbitt, E https://orcid.org/0000-0002-6650-9702	en_US
dc.contributor.author	Klein, WMP	en_US
dc.date.issued	2019-10-01	en_US
dc.identifier.citation	Journal of Community Genetics, 2019, 10 (4), pp. 453 - 459	en_US
dc.identifier.issn	1868-310X	en_US
dc.identifier.uri	http://hdl.handle.net/10453/136315
dc.description.abstract	© 2019, Springer-Verlag GmbH Germany, part of Springer Nature. The study objective was to examine bivariate and multivariate associations among worry, perceptions, attitudes, sociodemographics, and uptake of cancer-related germline genetic testing. We used data from the Health Information National Trends Survey (cycle 5.1), administered (January–May 2017) to a nationally representative sample of non-institutionalized adults (n = 3285). Those who had “heard about genetic tests that determine how a disease can be treated” had a higher likelihood of Lynch syndrome and BRCA1/2 testing (aRR = 2.57, p < 0.01; aRR = 3.23, p < 0.04). Attitudinal and psychosocial variables were not associated with uptake. Future research should explore ways to educate the public about the potential use of genetics in treatment decision-making.	en_US
dc.relation.ispartof	Journal of Community Genetics	en_US
dc.relation.isbasedon	10.1007/s12687-018-00405-4	en_US
dc.title	Psychosocial, attitudinal, and demographic correlates of cancer-related germline genetic testing in the 2017 Health Information National Trends Survey	en_US
dc.type	Journal Article
utslib.citation.volume	4	en_US
utslib.citation.volume	10	en_US
utslib.for	0604 Genetics	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
utslib.copyright.status	closed_access
pubs.issue	4	en_US
pubs.publication-status	Published	en_US
pubs.volume	10	en_US

Abstract:

© 2019, Springer-Verlag GmbH Germany, part of Springer Nature. The study objective was to examine bivariate and multivariate associations among worry, perceptions, attitudes, sociodemographics, and uptake of cancer-related germline genetic testing. We used data from the Health Information National Trends Survey (cycle 5.1), administered (January–May 2017) to a nationally representative sample of non-institutionalized adults (n = 3285). Those who had “heard about genetic tests that determine how a disease can be treated” had a higher likelihood of Lynch syndrome and BRCA1/2 testing (aRR = 2.57, p < 0.01; aRR = 3.23, p < 0.04). Attitudinal and psychosocial variables were not associated with uptake. Future research should explore ways to educate the public about the potential use of genetics in treatment decision-making.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/136315